Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with VRDN: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
VRDN
Viridian Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
VRDN
Viridian Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
VRDN
Viridian Therapeutics, Inc.
Change
28.53
▼
−1.82%
· post 28.53
Closed
Nov 5 '26
Mkt cap
$3.2B
Revenue
$26M
Q3 FY26
Revenue
$71M
FY25
vs
Compare
Closed
Nov 5 '26
LLY
ELI Lilly & Co
vs
VRDN
Viridian Therapeutics, Inc.
1,371.32
▼
−3.29%
post 1,363.77
Price
28.53
▼
−1.82%
post 28.53
$1.2T
Mkt cap
$3.2B
Q3 FY26
$24.4B
Revenue
$26M
Q3 FY26
FY25
$65.2B
Revenue
$71M
FY25
Change
Change
LLY
1,371.32
▼
−3.29%
vs
VRDN
28.53
▼
−1.82%
Closed
Nov 5 '26
Co-movers
daily closes
Method
›
Moved together
LLY
with
VRDN
Uncorrelated: r 0.21 · 500D.
No shared co-movers.
LLY, solid
VRDN, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes